daunorubicin has been researched along with Chronic Disease in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (38.46) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 2 (7.69) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, S; Burnett, AK; Cahalin, P; Clark, RE; Hills, RK; Kjeldsen, L; Russell, NH; Thomas, IF | 1 |
| Cheng, B; Du, J; Fu, MH; Pan, YY; Tao, XF | 1 |
| Adamcová, M; Holečková, M; Jirkovská, A; Karabanovich, G; Kocúrová-Lengvarská, J; Kollárová-Brázdová, P; Kubeš, J; Lenčová-Popelová, O; Mazurová, Y; Roh, J; Šimůnek, T; Štěrba, M; Štěrbová-Kovaříková, P; Váňová, N | 1 |
| Fan, B; Ge, J; Ge, L; Lu, H; Ma, J; Qian, J; Zhong, X | 1 |
| Fang, QJ; He, RL; Lian, JB; Wang, RX; Wu, ZJ; Yu, J | 1 |
| Adamcová, M; Bureš, J; Hroch, M; Jansová, H; Jirkovská-Vávrová, A; Jirkovský, E; Kovaříková, P; Lenčová-Popelová, O; Mazurová, Y; Pokorná, Z; Reimerová, P; Šimůnek, T; Štěrba, M; Vostatková, L | 1 |
| Dhall, G; Ettinger, LJ; Kurer, CC; Mahadeo, KM | 1 |
| Adamcová, M; Aupperle, H; Geršl, V; Mazurová, Y; Popelová, O; Potáčová, A; Štěrba, M | 1 |
| Cusack, BJ; Gabliel, H; Olson, RD; Young, SP | 1 |
| Adamcová, M; Čajnáková, H; Gersl, V; Hrbatová, L; Ponka, P; Popelová, O; Potáčová, A; Šimůnek, T; Sterba, M | 1 |
| Ferrans, VJ | 1 |
| Borgers, M | 1 |
| Ezaki, K; Hirano, M; Ino, T; Miyazaki, H; Okamoto, M; Tsuzuki, M | 1 |
| Chong, R; Goh, YT; Lee, LH; Ng, HS; Tan, P; Wong, GC | 1 |
| Balazs, T; Ferrans, VJ | 1 |
| Kuntz, HD | 1 |
| Page Thomas, DP; Phillips, NC | 1 |
| Hennemann, HH | 1 |
| Abdulkadyrov, KM; Bessmel'tsev, SS; Liubimova, NIu | 1 |
| Abdulkadyrov, KM; Bessmel'tsev, SS; Katsadze, IuL | 1 |
| Chandy, M; Patel, AP; Sudarsanam, A | 1 |
| Ferrans, VJ; Herman, EH | 1 |
| Faĭnshteĭn, FE | 1 |
| Buja, LM; Ferrans, VJ; Roberts, WC | 1 |
| Obrecht, P | 1 |
| Webb, HE | 1 |
5 review(s) available for daunorubicin and Chronic Disease
| Article | Year |
|---|---|
Anthracycline cardiotoxicity.
Topics: Acute Disease; Animals; Antibiotics, Antineoplastic; Arrhythmias, Cardiac; Cardiomyopathies; Chronic Disease; Daunorubicin; Dogs; Doxorubicin; Heart; Heart Failure; Humans; Mice; Naphthacenes; Organ Size; Pericarditis; Rabbits; Rats; Swine | 1983 |
Cardiac lesions induced by chemicals.
Topics: Acute Disease; Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Cardiomyopathies; Cardiovascular System; Chronic Disease; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Heart Diseases; Humans; Species Specificity | 1978 |
[Therapy of leukemia].
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Antimetabolites, Antineoplastic; Asparaginase; Child; Chronic Disease; Cyclophosphamide; Daunorubicin; Doxorubicin; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Vincristine | 1976 |
[Clinical aspects of the problem of treating leukemias].
Topics: Acute Disease; Antineoplastic Agents; Chlorambucil; Chlorine; Chronic Disease; Daunorubicin; Dimethoate; Drug Therapy, Combination; Ethylamines; Glucocorticoids; Humans; Immunoglobulins; Immunosuppression Therapy; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphocytosis; Mercaptopurine; Methotrexate; Prednisolone; Remission, Spontaneous | 1973 |
Drug-induced cardiomyopathies.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Cardiomyopathies; Child; Child, Preschool; Chronic Disease; Cobalt; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Heart; Heart Ventricles; Humans; Hypersensitivity; Male; Microscopy, Electron; Middle Aged; Myocardium | 1974 |
1 trial(s) available for daunorubicin and Chronic Disease
| Article | Year |
|---|---|
A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Clofarabine; Cytarabine; Daunorubicin; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid, Acute; United Kingdom; Vidarabine | 2022 |
20 other study(ies) available for daunorubicin and Chronic Disease
| Article | Year |
|---|---|
Safety and efficacy of a low frame rate protocol for percutaneous coronary intervention for chronic total occlusions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Coronary Angiography; Coronary Occlusion; Cytarabine; Daunorubicin; Humans; Percutaneous Coronary Intervention; Podophyllotoxin; Thioguanine; Treatment Outcome | 2021 |
Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo.
Topics: Animals; Cardiomyopathies; Cardiotoxicity; Chronic Disease; Daunorubicin; Diketopiperazines; Disease Models, Animal; DNA Damage; Fibrosis; HL-60 Cells; Humans; Male; Myocytes, Cardiac; Prodrugs; Rabbits; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2021 |
Safety and feasibility of a low frame rate protocol for percutaneous coronary intervention to chronic total occlusions: preliminary experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Coronary Angiography; Coronary Occlusion; Cytarabine; Daunorubicin; Feasibility Studies; Humans; Percutaneous Coronary Intervention; Podophyllotoxin; Registries; Thioguanine; Treatment Outcome | 2018 |
[Establishment and evaluation of daunorubicin-induced immature rat chronic heart failure model].
Topics: Animals; Animals, Newborn; Chronic Disease; Daunorubicin; Disease Models, Animal; Heart Failure; Rats; Rats, Sprague-Dawley | 2013 |
Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiotonic Agents; Cardiotoxicity; Cell Line, Tumor; Cell Proliferation; Chronic Disease; Daunorubicin; Doxorubicin; Heart Diseases; Heart Failure; Lipid Peroxidation; Molsidomine; Nitric Oxide Donors; Oxidative Stress; Rabbits; Reactive Oxygen Species; Ventricular Remodeling | 2016 |
Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction.
Topics: Adolescent; Antibiotics, Antineoplastic; Cardiomyopathies; Chronic Disease; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Natriuretic Peptide, Brain; Tretinoin | 2010 |
Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiovascular Agents; Chronic Disease; Collagen; Daunorubicin; Disease Models, Animal; Drug Interactions; Fibrosis; Hydroxyproline; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardium; Rabbits; Razoxane; Ventricular Remodeling | 2010 |
Effect of aging on cardiac contractility in a rat model of chronic daunorubicin cardiotoxicity.
Topics: Aging; Animals; Antibiotics, Antineoplastic; Calcium Channels; Cholesterol; Chronic Disease; Creatinine; Daunorubicin; Depression, Chemical; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Diseases; Heart Ventricles; Male; Models, Cardiovascular; Myocardial Contraction; Myocardium; Rats; Rats, Inbred F344; Sarcoplasmic Reticulum; Time Factors; Triglycerides; Ventricular Function, Left | 2002 |
Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents.
Topics: Aldehydes; Animals; Cardiomyopathies; Cardiotonic Agents; Chronic Disease; Daunorubicin; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocardiography; Heart Conduction System; Hydrazones; Iron Chelating Agents; Male; Myocardial Contraction; Pyridoxal; Rabbits; Razoxane; Time Factors; Troponin T | 2007 |
The role of calcium in the toxicity of the myocardium.
Topics: Acute Disease; Animals; Calcium; Cardiomyopathies; Chronic Disease; Coronary Disease; Daunorubicin; Dogs; Doxorubicin; Heart; Humans; Isoproterenol; Microscopy, Electron; Mitochondria, Heart; Myocardium | 1981 |
[Long-term selective beta 1-blockade therapy for a patient with anthracycline-induced cardiomyopathy].
Topics: Aclarubicin; Adrenergic beta-Antagonists; Adult; Antibiotics, Antineoplastic; Cardiomyopathy, Hypertrophic; Chronic Disease; Daunorubicin; Drug Administration Schedule; Female; Heart Failure; Humans; Leukemia, Myelomonocytic, Acute; Metoprolol; Mitoxantrone | 1995 |
Exacerbation of hepatitis in hepatitis B carriers following chemotherapy for haematological malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carrier State; Chronic Disease; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Doxorubicin; Etoposide; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1996 |
[Monocytic leukemia. Analysis of clinical and hematological data in 21 patients (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Aged; Bone Marrow Examination; Chronic Disease; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Monocytes; Sternum; Vincristine | 1977 |
Intra-articular liposomal therapy.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Chronic Disease; Daunorubicin; Forecasting; Humans; Hydrocortisone; Ions; Liposomes; Methods; Pharmaceutical Vehicles; Phosphatidylcholines; Solubility; Structure-Activity Relationship; Temperature | 1979 |
[Immunological and rheological disorders in multiple myeloma patients].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Viscosity; Chronic Disease; Cyclophosphamide; Daunorubicin; Female; Heart Failure; Humans; Immunity, Cellular; Kidney Failure, Chronic; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrogen Mustard Compounds; Prednisolone; Vincristine | 1991 |
[The effect of different programs of cytostatic therapy on the blood coagulation and rheological properties in multiple myeloma patients].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Blood Viscosity; Chronic Disease; Cyclophosphamide; Daunorubicin; Drug Evaluation; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrogen Mustard Compounds; Prednisolone; Vincristine | 1991 |
Refractory chronic pure red cell aplasia (PRCA) treated with vincristine and daunorubicin.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Daunorubicin; Humans; Immunosuppression Therapy; Male; Red-Cell Aplasia, Pure; Vincristine | 1991 |
Examination of the potential long-lasting protective effect of ICRF-187 against anthracycline-induced chronic cardiomyopathy.
Topics: Animals; Cardiomyopathies; Chronic Disease; Daunorubicin; Male; Myocardium; Myofibrils; Rabbits; Razoxane; Time Factors; Vacuoles | 1990 |
[Chemotherapy of leukemia].
Topics: Acute Disease; Antineoplastic Agents; Asparaginase; Chronic Disease; Cyclophosphamide; Daunorubicin; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1968 |
Management of virus cental nervous system disease.
Topics: Chronic Disease; Coma; Dactinomycin; Daunorubicin; Dexamethasone; Encephalomyelitis; Fever; Headache; Humans; Idoxuridine; Leukopenia; Meningitis, Viral; Mental Disorders; Pain; Paralysis; Respiratory Insufficiency; Rifampin; Vomiting | 1969 |